Company intelligence / Profile preview

SYNLAB

Ownership: Private
Employees: ~20000
Development stage: Commercial

Overview

SYNLAB operates one of the largest clinical laboratory networks in Europe and globally. It conducts approximately 600 million tests annually across more than 30 countries. The company leads in innovation for medical diagnostics with a focus on personalized medicine and evidence-based healthcare. Its research institute IRCCS SDN SYNLAB in Naples exemplifies its commitment to translating science into clinical practice. The group collaborates extensively with universities and research centers to advance diagnostic science

Therapeutic areas: Other
Industry: Molecular Diagnostics

Partnerships

National Health Service (NHS) UK contract for pathology servicesCollaborations with global public health institutions

Beyond the preview

Go deeper on SYNLAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SYNLAB.

Explore the full profile